Elligo Launches SOAR


Applied Clinical Trials

Elligo Health Research, a healthcare-enabling research organization, is launching their System of Accelerated Research (SOAR) model for decentralized (DCTs) and hybrid trial models with fully remote monitoring capabilities.

Elligo’s SOAR model expands patient access to reach diverse patient populations that typically don’t have access to clinical research as a care option. The solution drives efficiency by enabling direct data from source to submission and full remote site access, empowering patients, physicians, and sponsors to conduct more trials efficiently and faster in traditional and decentralized models.

“We are extremely excited to launch our tech-enabled solution created to keep the patient and the physician at the heart of its design, while providing sponsors transparency,” said John Potthoff, PhD, CEO of Elligo. “Our goal has always been to provide all patients with access to research as a healthcare option, which is important now more than ever as we navigate the future of clinical research.”

SOAR aims to adhere to regulations and improves data quality while decreasing resource requirements and costs associated with clinical research. Paired with technology-enabled services and personnel, this model accelerates research without compromising quality and integrity. This provides a pathway to either use traditional research sites, DCTs, or hybrid trials, seamlessly moving between options without causing disruption for any stakeholders. This modernizes clinical research for a new paradigm in a new age of clinical research.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.